ARCHIVES

Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

DCCP To Have Board Of Scientific Counselors

September 1, 1978

NCI, NEI Announce Interest In Grants On Ocular, Melanoma

November 21, 1980

NCI Toughens Criteria for MERIT Awards

February 23, 1996

Part II of Q&A With NCI Director Harold Varmus

July 29, 2011